p53 and its downstream proteins as molecular targets of cancer

Molecular Carcinogenesis

Volumn 45, Issue 6, 2006, Pages 409-415

  Sun, Yi ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Anticancer drug discovery; Cancer target identification and validation; Chip profiling; SAK

Indexed keywords

4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; ENZYME INHIBITOR; ETOPOSIDE; GELDANAMYCIN; MDM2 PROTEIN INHIBITOR; NUTLIN; POLO LIKE KINASE; PROLINE RICH MEMBRANE ANCHOR 1; PROTEIN INHIBITOR; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; SNK PLK AKIN KINASE; TRANSCRIPTOME; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONFERENCE PAPER; ENZYME ACTIVITY; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INDUCTION; GENE MUTATION; GENE REPRESSION; GENE SILENCING; HIGH THROUGHPUT SCREENING; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SAK GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 33744974524     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20231     Document Type: Conference Paper

References (31)

1. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.
2. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003;3:17-22.
3. Nguyen JT, Wells JA. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci USA 2003;100:7533-7538.
4. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
5. Vogelstein E, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-310.
6. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11:577-590.
7. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-1014.
8. Giaccia AJ, Kastan MB. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev 1998;12:2973-2983.
9. Foster BA, Coffey HA, Morin MJ, Rastinejad F. Pharmacological rescue of mutant p53 conformation and function. Science 1999;286:2507-2510.
10. Bykov VJ, Issaeva N, Shilov A, et al. Restoration of the tumor suppressor function to mutant p53 by a low molecular-weight compound. Nat Med 2002;8:282-288.
11. Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004;303:844-848.
12. Issaeva N, Bozko P, Enge M, et al. Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med 2004;10:1321-1328.
13. Ding K, Lu Y, Nikolovska-Coleska Z, et al. Structure-based design of potent non-peptide MDM2 inhibitors. J Am Chem Soc 2005;127:10130-10131.
14. Yang Y, Ludwig RL, Jensen JP, et al. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell 2005;7:547-559.
15. Blagosklonny MV, Toretsky J, Neckers L. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 1995;11:933-939.
16. Blagosklonny MV, Trostel S, Kayastha G, et al. Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. Cancer Res 2005;65:7386-7392.
17. Fang L, Li G, Liu G, Lee SW, Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 2001;20:1931-1939.
18. Han JA, Kim JI, Ongusaha PP, et al. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 2002;21:5635-5644.
19. Ongusaha PP, Kim JI, Fang L, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 2003;22:1289-1301.
20. Mortensen K, Skouv J, Hougaard DM, Larsson LI. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 1999;274:37679-37684.
21. Lopez CD, Ao Y, Rohde LH, et al. Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53. Mol Cell Biol 2000;20:8018-8025.
22. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005;435:677-681.
23. Wang Y, Sun Y. Insulin-like growth factor receptor-1 as an anti-cancer target: Blocking transformation and inducing apoptosis. Curr Cancer Drug Targets 2002;2:191-207.
24. Pochampally R, Fodera B, Chen L, Lu W, Chen J. Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem 1999;274:15271-15277.
25. Robinson M, Jiang P, Cui J, et al. Global Genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinomas. Cancer Biol Ther 2003;2:406-415.
26. Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM. The mitotic roles of Polo-like kinase. J Cell Sci 2001;114:2357-2358.
27. Hudson JW, Kozarova A, Cheung P, et al. Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr Biol 2001;11:441-446.
28. Yamashita Y, Kajigaya S, Yoshida K, et al. Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase. J Biol Chem 2001;276:39012-39020.
29. Macmillan JC, Hudson JW, Bull S, Dennis JW, Swallow CJ. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann Surg Oncol 2001;8:729-740.
30. Ko MA, Rosario CO, Hudson JW, et al. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat Genet 2005;37:883-888.
31. Li J, Tan M, Li L, Pamarthy D, Lawrence TS, Sun Y. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia 2005;7:312-323.